Research Progress of Metabolomics in Cervical Cancer

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2023 Dec 14

PMID 38093395

Authors

Yuhan Jia

Kun Zou

Lijuan Zou

Affiliations

Soon will be listed here.

Abstract

Introduction: Cervical cancer threatens women's health seriously. In recent years, the incidence of cervical cancer is on the rise, and the age of onset tends to be younger. Prevention, early diagnosis and specific treatment have become the main means to change the prognosis of cervical cancer patients. Metabolomics research can directly reflect the changes of biochemical processes and microenvironment in the body, which can provide a comprehensive understanding of the changes of metabolites in the process of disease occurrence and development, and provide new ways for the prevention and diagnosis of diseases.

Objectives: The aim of this study is to review the metabolic changes in cervical cancer and the application of metabolomics in the diagnosis and treatment.

Methods: PubMed, Web of Science, Embase and Scopus electronic databases were systematically searched for relevant studies published up to 2022.

Results: With the emergence of metabolomics, metabolic regulation and cancer research are further becoming a focus of attention. By directly reflecting the changes in the microenvironment of the body, metabolomics research can provide a comprehensive understanding of the patterns of metabolites in the occurrence and development of diseases, thus providing new ideas for disease prevention and diagnosis.

Conclusion: With the continuous, in-depth research on metabolomics research technology, it will bring more benefits in the screening, diagnosis and treatment of cervical cancer with its advantages of holistic and dynamic nature.

Citing Articles

A Zeolitic Imidazolate Framework-Based Antimicrobial Peptide Delivery System with Enhanced Anticancer Activity and Low Systemic Toxicity.

Jiang J, Kaysar K, Pan Y, Xia L, Li J Pharmaceutics. 2025; 16(12.

PMID: 39771569 PMC: 11678129. DOI: 10.3390/pharmaceutics16121591.

YTHDF1 boosts the lactate accumulation to potentiate cervical cancer cells immune escape.

Xiong J, He L, Chai X, Zhang Y, Sun S Cell Death Dis. 2024; 15(11):843.

PMID: 39557826 PMC: 11573975. DOI: 10.1038/s41419-024-07128-0.

Construction of a nomogram for personalized prediction of lower limb lymphedema risk after cervical cancer surgery.

Chen X, Li J, Zeng Q, Huang W, Lei N, Zeng Q BMC Womens Health. 2024; 24(1):593.

PMID: 39506697 PMC: 11539278. DOI: 10.1186/s12905-024-03422-3.

Treatment of secondary uterine malignancy following radiotherapy for cervical cancer: a study based on the SEER database.

Tong X, Xiao Y, Li H, Zhang H, Li J BMC Womens Health. 2024; 24(1):475.

PMID: 39210330 PMC: 11566153. DOI: 10.1186/s12905-024-03331-5.

Cervical mucus can be used for metabolite screening in cervical cancer.

Kawasaki R, Kukimoto I, Tsukamoto T, Nishio E, Iwata A, Fujii T Cancer Sci. 2024; 115(11):3672-3681.

PMID: 39171738 PMC: 11531950. DOI: 10.1111/cas.16323.

References

Suarez R . Energy and metabolism. Compr Physiol. 2013; 2(4):2527-40. DOI: 10.1002/cphy.c110009. View

Guo Y, Xu L, Zhang D, Liao Y, Wang H, Lan Z . Betaine Effects on Morphology, Proliferation, and p53-induced Apoptosis of HeLa Cervical Carcinoma Cells in Vitro. Asian Pac J Cancer Prev. 2015; 16(8):3195-201. DOI: 10.7314/apjcp.2015.16.8.3195. View

Zhang J, Pavlova N, Thompson C . Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017; 36(10):1302-1315. PMC: 5430235. DOI: 10.15252/embj.201696151. View

Doherty B, Lawlor D, Gillet J, Gottesman M, OLeary J, Stordal B . Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells. Anticancer Res. 2014; 34(1):503-7. View

Li T, Le A . Glutamine Metabolism in Cancer. Adv Exp Med Biol. 2018; 1063:13-32. DOI: 10.1007/978-3-319-77736-8_2. View

Manchester M, Anand A . Metabolomics: Strategies to Define the Role of Metabolism in Virus Infection and Pathogenesis. Adv Virus Res. 2017; 98:57-81. DOI: 10.1016/bs.aivir.2017.02.001. View

Skara L, Hudek Turkovic A, Pezelj I, Vrtaric A, Sincic N, Kruslin B . Prostate Cancer-Focus on Cholesterol. Cancers (Basel). 2021; 13(18). PMC: 8469848. DOI: 10.3390/cancers13184696. View

Tyszka-Czochara M, Bukowska-Strakova K, Kocemba-Pilarczyk K, Majka M . Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines. Nutrients. 2018; 10(7). PMC: 6073805. DOI: 10.3390/nu10070841. View

Hu Y, Qi Y, Liu H, Fan G, Chai Y . Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling. Biochim Biophys Acta. 2012; 1830(3):2779-89. DOI: 10.1016/j.bbagen.2012.10.024. View

10.

Dang C . Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?. Cell Cycle. 2010; 9(19):3884-6. DOI: 10.4161/cc.9.19.13302. View

11.

Jelic M, Mandic A, Maricic S, Srdjenovic B . Oxidative stress and its role in cancer. J Cancer Res Ther. 2021; 17(1):22-28. DOI: 10.4103/jcrt.JCRT_862_16. View

12.

Basu J, Mikhail M, Ahn C, Furguiele J, Ho G, Burk R . Plasma uric acid levels in women with cervical intraepithelial neoplasia. Nutr Cancer. 2005; 51(1):25-31. DOI: 10.1207/s15327914nc5101_4. View

13.

Tavakoli F, Khatami S, Momeni F, Azadbakht J, Ghasemi F . Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques. Comb Chem High Throughput Screen. 2020; 24(5):605-623. DOI: 10.2174/1386207323666200901101955. View

14.

Popalis M, Ramirez S, Leach K, Granzow M, Stoltzfus K, Moss J . Improving cervical cancer screening rates: a scoping review of resources and interventions. Cancer Causes Control. 2022; 33(11):1325-1333. PMC: 10124066. DOI: 10.1007/s10552-022-01618-2. View

15.

Chouchani E, Pell V, Gaude E, Aksentijevic D, Sundier S, Robb E . Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014; 515(7527):431-435. PMC: 4255242. DOI: 10.1038/nature13909. View

16.

Chan E, Koh P, Mal M, Cheah P, Eu K, Backshall A . Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 2008; 8(1):352-61. DOI: 10.1021/pr8006232. View

17.

Gray L, Tompkins S, Taylor E . Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci. 2013; 71(14):2577-604. PMC: 4059968. DOI: 10.1007/s00018-013-1539-2. View

18.

Cluntun A, Lukey M, Cerione R, Locasale J . Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer. 2017; 3(3):169-180. PMC: 5383348. DOI: 10.1016/j.trecan.2017.01.005. View

19.

Tapiero H, MATHE G, Couvreur P, Tew K . II. Glutamine and glutamate. Biomed Pharmacother. 2002; 56(9):446-57. DOI: 10.1016/s0753-3322(02)00285-8. View

20.

Ning Y, Wang C, Liu X, Du Y, Liu S, Liu K . CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression. J Exp Clin Cancer Res. 2019; 38(1):131. PMC: 6423756. DOI: 10.1186/s13046-019-1137-8. View